Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 28 studies | 33% ± 13% | |
adipocyte | 10 studies | 53% ± 15% | |
oligodendrocyte | 9 studies | 33% ± 13% | |
GABAergic neuron | 5 studies | 33% ± 10% | |
glutamatergic neuron | 4 studies | 38% ± 10% | |
mesothelial cell | 4 studies | 29% ± 18% | |
connective tissue cell | 4 studies | 23% ± 4% | |
endothelial cell | 3 studies | 38% ± 25% | |
adventitial cell | 3 studies | 45% ± 10% | |
granule cell | 3 studies | 32% ± 11% | |
interneuron | 3 studies | 26% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 33% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 15088.66 | 454 / 459 | 89% | 6.70 | 995 / 1118 |
lung | 99% | 12422.37 | 573 / 578 | 89% | 5.28 | 1024 / 1155 |
intestine | 87% | 5486.29 | 844 / 966 | 72% | 3.23 | 382 / 527 |
bladder | 90% | 5897.19 | 19 / 21 | 69% | 2.30 | 349 / 504 |
esophagus | 74% | 4740.52 | 1073 / 1445 | 85% | 4.20 | 155 / 183 |
uterus | 92% | 6010.15 | 157 / 170 | 65% | 2.45 | 297 / 459 |
skin | 84% | 12248.30 | 1521 / 1809 | 51% | 2.01 | 243 / 472 |
pancreas | 40% | 1011.63 | 130 / 328 | 96% | 8.67 | 170 / 178 |
thymus | 93% | 4926.03 | 610 / 653 | 40% | 1.51 | 244 / 605 |
stomach | 52% | 3942.80 | 186 / 359 | 80% | 4.28 | 228 / 286 |
kidney | 49% | 2008.49 | 44 / 89 | 65% | 3.75 | 589 / 901 |
adipose | 100% | 24052.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 59% | 1850.86 | 153 / 258 | 40% | 3.60 | 93 / 230 |
blood vessel | 93% | 5993.53 | 1237 / 1335 | 0% | 0 | 0 / 0 |
prostate | 16% | 635.54 | 38 / 245 | 69% | 2.06 | 348 / 502 |
ovary | 36% | 1997.97 | 64 / 180 | 48% | 2.14 | 207 / 430 |
brain | 19% | 687.00 | 493 / 2642 | 58% | 1.69 | 407 / 705 |
spleen | 76% | 2544.51 | 182 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 2.02 | 31 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.65 | 17 / 29 |
heart | 50% | 1742.68 | 429 / 861 | 0% | 0 | 0 / 0 |
liver | 5% | 139.08 | 11 / 226 | 36% | 1.29 | 146 / 406 |
muscle | 28% | 1097.44 | 226 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.16 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008544 | Biological process | epidermis development |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0045959 | Biological process | negative regulation of complement activation, classical pathway |
GO_0003017 | Biological process | lymph circulation |
GO_0120193 | Biological process | tight junction organization |
GO_0048014 | Biological process | Tie signaling pathway |
GO_0036303 | Biological process | lymph vessel morphogenesis |
GO_0045906 | Biological process | negative regulation of vasoconstriction |
GO_0010467 | Biological process | gene expression |
GO_0010572 | Biological process | positive regulation of platelet activation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003682 | Molecular function | chromatin binding |
GO_0005178 | Molecular function | integrin binding |
GO_0098640 | Molecular function | integrin binding involved in cell-matrix adhesion |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SVEP1 |
Protein name | Alternative protein SVEP1 Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) |
Synonyms | SELOB CCP22 C9orf13 |
Description | FUNCTION: Required for morphological development, cell alignment and migration of lymphatic endothelial cells during embryonic development, potentially via modulation of ANGPT2-TIE1 signaling and subsequent activation of FOXC2 transcription (By similarity). Required for embryonic lymphatic vascular development, via mediating the correct formation of the first lymphovenous contact site and tight association of the lymphatic endothelium with the venous endothelium (By similarity). Represses PRKCA-mediated L-type voltage-gated channel Ca(2+) influx and ROCK-mediated calcium sensitivity in vascular smooth muscle cells, via its interaction with integrins, thereby inhibiting vasocontraction . Promotes platelet activation, via its interaction with PEAR1 and subsequent activation of AKT/mTOR signaling . Plays a role in epidermal development and keratinocyte differentiation, independent of cell-cell adhesion . May play a role in initial cell attachment of stromal osteogenic cells (By similarity). May promote myoblast cell adhesion when in the presence of integrin ITGA9:ITGB1 (By similarity). . |
Accessions | Q4LDE5 L8EBF2 ENST00000374469.6 [Q4LDE5-1] ENST00000374461.1 [Q4LDE5-2] |